ABBV
$230.01
Revenue | $15776Mn |
Net Profits | $186Mn |
Net Profit Margins | 1.18% |
Abbvie Inc’s revenue jumped 9.1% since last year same period to $15776Mn in the Q3 2025. On a quarterly growth basis, Abbvie Inc has generated 2.29% jump in its revenue since last 3-months.
Abbvie Inc’s net profit fell -88.08% since last year same period to $186Mn in the Q3 2025. On a quarterly growth basis, Abbvie Inc has generated -80.3% fall in its net profits since last 3-months.
Abbvie Inc’s net profit margin fell -89.08% since last year same period to 1.18% in the Q3 2025. On a quarterly growth basis, Abbvie Inc has generated -80.74% fall in its net profit margins since last 3-months.
EPS Estimate Current Quarter | 3.35 |
EPS Estimate Current Year | 3.35 |
Abbvie Inc’s earning per share (EPS) estimates for the current quarter stand at 3.35 - a 2.45% jump from last quarter’s estimates.
Abbvie Inc’s earning per share (EPS) estimates for the current year stand at 3.35.
Earning Per Share (EPS) | 1.86 |
Dividend Per Share (DPS) | 1.64 |
Abbvie Inc’s earning per share (EPS) fell -38% since last year same period to 1.86 in the Q3 2025. This indicates that the Abbvie Inc has generated -38% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Abbvie Inc declared 1.64 dividend per share during the earnings announcement for Q3 2025.
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2025-05-09 | 2.4 | 2.46 | 2.5% |
2025-08-04 | 2.91 | 2.97 | 2.06% |
2025-11-04 | 3.27 | 1.86 | -43.12% |